The Economics of Live Music How Blue Dot Fever and Rising Prices Are Reshaping Concert Spending Burberry Shares Rise on Report of Potential Moncler Bid Dropbox Founder Drew Houston to Step Down as CEO After Nearly Two Decades Transition to Executive Chairman Federal Reserve Faces Diminishing Case for Rate Cuts as Jobs Data Signals Sticky Inflation AnheuserBusch InBev Shares Decline as Quarterly Sales Miss Analyst Expectations Bharat Dynamics Q4 2026 Net Profit Slumps 59 YoY to 113 Crore Final Dividend of 040 Announced Saratoga Investment Corp SAY Q1 2026 Earnings Significant EPS Miss Despite Slight Stock Uptick ONB Q1 2026 Earnings Slight EPS Miss Amid Stable Market Conditions Compass Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Pipeline Progress APLS Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency NNOX Q4 2025 Earnings WiderThanExpected Loss as Revenue Details Remain Scarce GLXY Q1 2026 Earnings EPS Misses Estimates as Loss Widens Stock Climbs 648 Despite Disappointment MicroVision Inc MVIS Faces Selling Pressure Holds Above Key Support Trinity Capital Notes TRINI Edge Higher as Yield Stability Attracts Steady Demand Beazer Homes BZH Rallies 146 as Homebuilder Tests Key Resistance Near 2558 PolyPid Shares Edge Lower as Stock Nears Key Support Zone AtlasClear Holdings ATCH Hovers Near Support Amid Mild Selling Tracker Mortgages Regain Popularity Amid Uncertain Rate Outlook and Economic Turbulence AVX Q1 2026 Earnings Loss Per Share and Stock Decline Highlight Challenges America Movil AMX Holds Above Key Support After Modest Decline InMode INMD Rebounds 163 as Shares Find Support Near 1334 Cathay General Bancorp CATY Posts Modest Gain Holds Above Key Support Stellar Bancorp STEL Holds Near Support as Modest Decline Tests Investor Sentiment 1800FLOWERSCOM FLWS Gains Ground as Support Holds Resistance Ahead Artivion Inc AORT Slides 136 as Stock Tests Key Support Levels Amid Sector Headwinds Gyre Therapeutics GYRE Declines 31 as Stock Tests Key Support Near 545 Janux Therapeutics JANX Rises 26 as Biotech Sentiment Improves